CathWorks Announces the Completion of Enrollment for Landmark ALL-RISE Randomized Controlled Trial

ALL-RISE Study Included Over 1,924 Patients in 59 Sites Across North America, Asia, Europe and the Middle East NEWPORT BEACH, Calif., ...

Cision | Fri, Jan 03 2025 05:30 AM AEDT

Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044

WUHAN, China, Jan. 3, 2025 /PRNewswire/ -- Hanx Biopharmaceuticals, CO. Ltd, an innovative biotechnology company developing next-generation immunotherapies to address the challenges ...

Cision | Fri, Jan 03 2025 04:43 AM AEDT

DXC Technology Names Brad Novak as Chief Information Officer

Veteran Technology Executive Joins DXC's Leadership Team ASHBURN, Va., Jan. 3, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading Fortune 500 global ...

Cision | Fri, Jan 03 2025 04:35 AM AEDT

Lexar to Showcase an Extensive Lineup of Products for Photographers, Filmmakers, and Gamers at CES 2025

SAN JOSE, Calif., Jan. 3, 2025 /PRNewswire/ -- Lexar, a leading global brand of flash memory solutions, is excited to announce their ...

Cision | Fri, Jan 03 2025 04:30 AM AEDT

Leading the Way To Net-Zero: Lenovo’s Science-Based Emissions Reduction Targets and 2050 Net-Zero Strategy

Originally published in Lenovo's 2023/24 ESG ReportLenovo has responded to the Science Based Targets initiative (SBTi)’s urgent call for corporate ...

3BL | Fri, Jan 03 2025 04:15 AM AEDT